IRF1 and Jeune syndrome: Of interest, a recent study identified SNP (_1623A/G) of the TG gene – previously identified as a major ATD susceptible variant – to modify a binding site for the IFN-induced transcription factor interferon regulatory factor-1 (IRF-1), leading to increased promoter activity and increased TG levels, a major antigenic target for ATD (23).